Compounds organized for investigations involving musculoskeletal and connective‑tissue models, including studies of tendon, ligament, and muscle‑associated signaling pathways in controlled research environments. This category is intended to support preclinical work on structural and load‑bearing tissue biology, not performance, physique, or rehabilitation programs. For Research Use Only. Not for human or animal use.
Showing all 19 results
5-amino 1-MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) Reduced adiposity, smaller adipocytes, and lower cholesterol without suppressing food intake. Recent work also reports improved muscle strength and regenerative capacity.
AOD-9604: Studied for Fat Metabolism, Weight Management & Metabolic Health
AOD-9604, a synthetic peptide derived from human growth hormone (hGH), has garnered significant interest in research settings for its potential effects on adipose tissue metabolism and lipid regulation.
BPC-157 peptide studied in preclinical tissue integrity and vascular signaling models. Available in 10mg and 40mg lyophilized vials. Third-party tested, 99% purity. For research use only.
Research Overview of the BPC-157 + TB-500 Peptide Combination “Wolverine Blend” The combination of BPC-157 and TB-500, commonly referred to as the Wolverine Blend in research communities, is one of the most frequently examined peptide pairings in modern preclinical literature. This pairing is studied for its complementary roles in angiogenesis, tissue repair, actin dynamics,…
The CJC-1295 (No DAC) and Ipamorelin blend, combining two synthetic peptides, is a research compound designed to stimulate growth hormone (GH) release through complementary mechanisms, offering a valuable tool for studying neuroendocrine regulation and metabolic pathways.
CJC-1295 (No DAC):
CJC-1295 without DAC- Investigated for its effects on GH and insulin-like growth factor-1 (IGF-1) secretion, it provides a valuable tool for studying neuroendocrine regulation, muscle growth, and metabolic processes.
GLP-2, a dual GLP-1 and GIP receptor agonist, has been studied for its potential impact on metabolic health, weight management, and insulin sensitivity. Research has explored how this dual-acting compound may influence appetite regulation, fat metabolism, and glucose control—areas of growing interest in obesity and metabolic disorder studies.
GLP-3, a triple incretin agonist, has demonstrated significant results in research models, with phase 2 trials showing up to 24.2% weight loss, a 2.02% HbA1c reduction, and up to 82% liver fat normalization. Studies also indicate its potential to reduce cardiovascular risk by 26.9% through lipid improvements and supported kidney function markers. Clinical research continues to explore the potential of multi-receptor peptides like GLP-3 as a central component of the evolving metabolic health landscape. As a next-generation GLP-1/GIP receptor agonist, research suggests it may offer advantages over earlier GLP-1 medications in areas like fat reduction, appetite regulation, and metabolic support.
GLP-3 peptide 30mg is an advanced triple hormone receptor agonist designed for high-precision metabolic research. By simultaneously targeting the GLP-1, GIP, and glucagon receptors, this synthetic compound allows researchers to investigate complex pathways involving appetite regulation, energy expenditure, and glycemic control in laboratory models. Each vial contains 30mg of high-purity, lyophilized powder.
What is GLP-3? GLP-3 is a synthetic research peptide designed to help labs study how multiple gut-hormone signals can work together in metabolic models. This GLP-3 peptide is supplied as a vial for controlled laboratory and preclinical research use. Because GLP-3 is studied in the same “multi-receptor” category as next-generation incretin agonists, it often appears…
IGF-1 LR3 is studied for its effects on muscle growth and recovery: A 15–20% increase in muscle fiber cross-sectional area in mice treated with 1 mg/kg/day for 14 days, linked to enhanced protein synthesis PMC, IGF-1 Muscle Repair
Ipamorelin, a synthetic pentapeptide, is a potent research tool investigated for its selective stimulation of growth hormone (GH) release, offering insights into metabolic regulation, muscle physiology, and neuroendocrine function. As a growth hormone secretagogue (GHS), it targets the ghrelin receptor to enhance GH secretion without significantly impacting other hormones, making it a valuable compound for controlled studies. Ipamorelin is strictly for investigational purposes.
Lean Peptide Blend, combining GLP-3 10mg and Cagrilintide 10mg, is an innovative research tool investigated for its synergistic effects on weight management, glucose regulation, and metabolic health.
What is MOTS-c? MOTS-c peptide 20mg is a synthetic research peptide that matches a short sequence naturally made inside the mitochondria, the “power plants” of cells. In this listing, MOTS-c peptide is supplied as a 20mg lyophilized (freeze-dried) powder in a single research vial for reconstitution and use in controlled lab models only. Researchers are…
Sermorelin, a synthetic peptide analog of growth hormone-releasing hormone (GHRH), is a valuable research tool investigated for its ability to stimulate growth hormone (GH) secretion in controlled laboratory settings. As a 29-amino-acid peptide, it mimics the endogenous GHRH to explore neuroendocrine regulation, metabolic processes, and tissue growth.
Tesamorelin: Muscle Growth, Fat Metabolism & Body Composition
Tesamorelin, a synthetic growth hormone-releasing hormone (GHRH) analog, has been studied for its potential role in stimulating natural growth hormone production, muscle growth, promoting fat metabolism, and supporting body composition.
Tesamorelin is a GHRH analog. Pre-clinical studies demonstrate a 3–4-fold increase in GH levels, 15–20% fat mass reduction, and 10–12% muscle growth, making it an interesting peptide for researchers looking to support muscle growth and fat loss.
Tesamorelin + Ipamorelin: Insights into Dual Pathway GH Secretagogue Synergy Introduction Tesamorelin and Ipamorelin are synthetic peptides that stimulate the release of growth hormone (GH) through distinct mechanisms within the hypothalamic–pituitary axis. Tesamorelin is an analog of growth hormone–releasing hormone (GHRH) with enhanced stability and half-life, while Ipamorelin is a selective growth hormone secretagogue that…
A tesamorelin–ipamorelin blend is a mechanistically coherent dual-receptor strategy to study GH pulsatility and its effects on visceral adiposity, fat, and metabolic biomarkers. Tesamorelin provides clinically demonstrated VAT and liver-fat signals, while ipamorelin contributes GH-selective GHSR activation
No products in the cart.
